Brain lesions are abnormal areas detected on imaging scans such as MRI or CT that suggest tissue damage or structural change. They can result from injury, infection, inflammation, tumors, or degenerative diseases and require clinical correlation to determine significance.
Lesions appear as dark or bright spots depending on the imaging modality and tissue characteristics. On T2-weighted MRI sequences, they typically show increased signal intensity due to fluid accumulation or demyelination. Their presence alone does not diagnose a condition-context matters.
For example, a 42-year-old woman presented with progressive weakness in her left arm and difficulty walking. An MRI revealed multiple hyperintense lesions in the right cerebral hemisphere and cerebellar white matter. Further testing confirmed multiple sclerosis, a chronic autoimmune disorder attacking myelin sheaths.
Lesions develop when brain tissue undergoes disruption to blood flow, cellular integrity, or immune activity. Common mechanisms include ischemia (reduced blood supply), hemorrhage (bleeding), infection (bacterial or viral), demyelination (loss of nerve insulation), or neoplastic growth (tumors).
Imaging detects these changes based on water content and tissue density. For instance, acute strokes cause restricted diffusion on DWI-MRI sequences, appearing bright on certain sequences. Chronic lesions may show gliosis-scarring from prior injury-and appear as hypointense or hyperintense regions depending on the sequence.
A 68-year-old man with sudden onset aphasia had a CT scan showing a hyperdense lesion in the left frontal lobe. Subsequent MRI confirmed an acute ischemic stroke involving Broca's area, responsible for speech production. This illustrates how lesion location correlates with specific neurological deficits.
Lesions vary widely in appearance and etiology. The following table outlines common categories, their typical imaging features, and associated conditions.
| Type | Appearance on MRI | Common Causes | Typical Patient Profile |
|---|---|---|---|
| Ischemic Stroke | Hyperintense on DWI, hypointense on ADC | Blood vessel occlusion, embolism | Older adults with hypertension, diabetes |
| Demyelinating (e.g., MS) | Periventricular, juxtacortical, or infratentorial plaques; T2/FLAIR hyperintense | Autoimmune attack on myelin | Young adults, especially women |
| Infectious (e.g., abscess) | Ring-enhancing lesion with surrounding edema | Bacteria, fungi, parasites | Immunocompromised patients, recent travel |
| Tumoral (primary or metastatic) | Mass effect, heterogeneous enhancement, necrosis | Glioblastoma, breast cancer spread | Patients with known malignancy or new-onset seizures |
| Post-traumatic | Subdural hematoma appears crescent-shaped; diffuse axonal injury shows microhemorrhages | Head injury, impact trauma | Recent accident victims, athletes |
Some lesions are incidental findings. A 2021 study published in Nature Neurology found that 12% of healthy adults aged 50-70 had asymptomatic white matter hyperintensities on MRI-often linked to small vessel disease rather than active pathology.
Many assume all brain lesions are cancerous or life-threatening. This is incorrect. Most are benign or stable over time. A lesion's size, location, enhancement pattern, and evolution matter more than its mere presence.
For example, a single enhancing lesion in the temporal lobe may raise suspicion for a tumor, but in a patient with a history of Lyme disease, it could represent a granulomatous inflammatory response. Without clinical context, imaging alone cannot confirm diagnosis.
Another misconception is equating lesion burden with symptom severity. Some patients with extensive white matter disease remain neurologically intact, while others with minimal lesions experience significant cognitive decline. Individual variability in brain reserve plays a role.
When a lesion is identified, clinicians assess symptoms, medical history, and imaging patterns. Follow-up scans may be ordered to monitor stability or progression. Additional tests include lumbar puncture (for infection or autoimmune markers), PET scans (to evaluate metabolic activity), or biopsy (if malignancy is suspected).
I once reviewed a case of a 35-year-old man with episodic headaches and mild memory lapses. Initial MRI showed scattered T2 hyperintensities in the frontal lobes. He was referred to a neurologist who ruled out multiple sclerosis through negative oligoclonal bands and normal CSF protein levels. Over 18 months, follow-up MRIs showed no change-indicating likely non-inflammatory, possibly vascular-related changes.
Lesions may not be symptomatic. A 2020 analysis in JAMA Neurology reported that nearly 40% of patients with brain lesions detected incidentally had no neurological symptoms at the time of discovery.
Seek immediate evaluation if lesions are accompanied by new-onset seizures, focal weakness, vision loss, confusion, or rapid cognitive decline. These signs suggest active pathology requiring intervention.
For less urgent cases, consult a neurologist to interpret results in context. Not every lesion requires treatment-some are stable, others resolve spontaneously.
Brain lesions indicate structural changes needing interpretation-not automatic alarm. Accurate diagnosis depends on integrating imaging, symptoms, and laboratory data. What do lesions on the brain indicate? They signal potential issues, but only through careful clinical assessment can their true meaning be known.